SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 155 filers reported holding SERES THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,034,651 | -49.2% | 5,476,744 | +2.2% | 0.00% | -100.0% |
Q2 2023 | $25,660,906 | -22.7% | 5,357,183 | -8.5% | 0.00% | 0.0% |
Q1 2023 | $33,187,281 | -2.7% | 5,853,136 | -3.9% | 0.00% | 0.0% |
Q4 2022 | $34,120,448 | -19.6% | 6,092,937 | -7.8% | 0.00% | 0.0% |
Q3 2022 | $42,442,000 | +132.1% | 6,610,856 | +24.0% | 0.00% | 0.0% |
Q2 2022 | $18,285,000 | -49.3% | 5,330,817 | +5.2% | 0.00% | 0.0% |
Q1 2022 | $36,076,000 | -7.4% | 5,066,930 | +8.4% | 0.00% | 0.0% |
Q4 2021 | $38,953,000 | +41.5% | 4,676,265 | +18.2% | 0.00% | 0.0% |
Q3 2021 | $27,535,000 | -66.1% | 3,956,272 | +16.2% | 0.00% | -50.0% |
Q2 2021 | $81,223,000 | +15.4% | 3,405,570 | -0.4% | 0.00% | 0.0% |
Q1 2021 | $70,403,000 | -9.3% | 3,419,277 | +8.0% | 0.00% | 0.0% |
Q4 2020 | $77,599,000 | -0.5% | 3,167,319 | +15.0% | 0.00% | -33.3% |
Q3 2020 | $78,004,000 | +625.8% | 2,755,345 | +22.0% | 0.00% | – |
Q2 2020 | $10,748,000 | +39.7% | 2,257,979 | +4.8% | 0.00% | – |
Q1 2020 | $7,694,000 | +4.2% | 2,155,156 | +0.7% | 0.00% | – |
Q4 2019 | $7,382,000 | -12.0% | 2,139,641 | +2.3% | 0.00% | – |
Q3 2019 | $8,390,000 | +26.5% | 2,092,286 | +1.6% | 0.00% | – |
Q2 2019 | $6,635,000 | +7.2% | 2,060,327 | +128.7% | 0.00% | – |
Q1 2019 | $6,191,000 | +61.0% | 901,032 | +5.9% | 0.00% | – |
Q4 2018 | $3,846,000 | -50.8% | 850,846 | -17.4% | 0.00% | – |
Q3 2018 | $7,815,000 | -35.8% | 1,029,643 | -27.3% | 0.00% | -100.0% |
Q2 2018 | $12,180,000 | -3.3% | 1,416,254 | -17.5% | 0.00% | 0.0% |
Q1 2018 | $12,596,000 | -20.1% | 1,716,067 | +10.4% | 0.00% | 0.0% |
Q4 2017 | $15,762,000 | -40.9% | 1,554,567 | -6.5% | 0.00% | 0.0% |
Q3 2017 | $26,681,000 | +49.0% | 1,663,373 | +4.9% | 0.00% | 0.0% |
Q2 2017 | $17,911,000 | +1.5% | 1,585,026 | +1.2% | 0.00% | 0.0% |
Q1 2017 | $17,645,000 | +21.9% | 1,565,663 | +7.1% | 0.00% | 0.0% |
Q4 2016 | $14,476,000 | -12.6% | 1,462,207 | +8.5% | 0.00% | 0.0% |
Q3 2016 | $16,558,000 | -51.6% | 1,347,194 | +14.5% | 0.00% | -50.0% |
Q2 2016 | $34,191,000 | +35.9% | 1,176,924 | +24.3% | 0.00% | 0.0% |
Q1 2016 | $25,151,000 | +31.6% | 946,954 | +73.8% | 0.00% | +100.0% |
Q4 2015 | $19,115,000 | +34.3% | 544,752 | +13.5% | 0.00% | 0.0% |
Q3 2015 | $14,232,000 | +1614.7% | 480,165 | +2300.8% | 0.00% | – |
Q2 2015 | $830,000 | – | 20,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |